Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAshmore Group Regulatory News (ASHM)

Share Price Information for Ashmore Group (ASHM)

Share Price is delayed by 15 minutes
Get Live Data
202.60    0.00 (0.00%)
Bid:
202.60
Ask:
203.00
Spread: 0.40 (0.197%)
Market Cap: £1.32b
ASHM Live PriceLast checked at - London Stock Exchange

Intraday Ashmore Group Share Chart

Q4 AuM Statement

10 Jul 2014 07:00

RNS Number : 9142L
Ashmore Group PLC
10 July 2014
 



Ashmore Group plc

+0700 10 July, 2014

FOURTH QUARTER ASSETS UNDER MANAGEMENT STATEMENT

Ashmore Group plc ("Ashmore", "the Group"), the specialist Emerging Markets asset manager, announces today the following update to its assets under management ("AuM") in respect of the quarter ended 30 June 2014.

Assets under Management

Investment theme

Actual31 March 2014

(US$ billion)

Estimated30 June 2014

(US$ billion)

Movement

Q4 vs Q3(%)

External debt

14.1

14.0

-0.7

Local currency

15.9

17.3

+8.8

Corporate debt

7.1

8.2

+15.5

Blended debt

18.6

20.6

+10.8

Equities

5.5

6.1

+10.9

Alternatives

2.5

2.5

-

Multi-strategy

2.4

2.7

+12.5

Overlay / liquidity

4.0

3.6

-10.0

Total

70.1

75.0

+7.0

 

Assets under management increased during the quarter to US$75.0 billion through a combination of net inflows totalling US$1.6 billion and positive investment performance of US$3.3 billion.

Net inflows were delivered across a range of fixed income and equities themes. The flows reflect a broad mix of clients by type and domicile, and were balanced in respect of mandate size. There was good demand for blended debt, corporate debt and local currency assets, while multi-strategy experienced institutional demand which offset the expected outflows from Japanese retail funds. There were net outflows in the external debt and overlay/liquidity themes.

Consistent implementation of the Group's long-standing investment processes resulted in portfolios buying into opportunities presented by the numerous periods of market weakness over the past 12 months. This approach has delivered positive investment performance over the quarter with all themes contributing except alternatives and overlay/liquidity, which were flat. Investment returns were particularly strong in the blended debt, local currency, external debt and equities themes.

Mark Coombs, Chief Executive Officer, Ashmore Group plc, commented:

"Improving sentiment and the consequent market recovery have benefited those investors who remained focused on the economic and political fundamentals in Emerging Markets and who took the opportunity to invest in mis-priced assets earlier in the year. Looking ahead, the prospects for investment returns are enhanced by the on-going development of the asset class. New countries being represented in indices broadens the diverse range of opportunities available and supports increasing allocations by dedicated investors."

For the translation of US dollar-denominated balance sheet items, the GBP/USD exchange rate was 1.7106 at 30 June 2014, a 3% weakening of the US dollar since 31 December 2013 (1.6557). For the translation of US dollar management fees, the average GBP/USD exchange rate achieved for the second half of the year was 1.6734 (H1 2013/14: 1.5868; FY2012/13: 1.5690).

Ashmore will announce its preliminary results in respect of the financial year to 30 June 2014 on 11 September 2014. There will be a presentation for analysts at 0900 on that date at the offices of Goldman Sachs at Peterborough Court, 133 Fleet Street, London, EC4M 2BB. A copy of the presentation will be made available on the Group's website at www.ashmoregroup.com.

For further information please contact:

Ashmore Group plcPaul MeasdayInvestor Relations +44 (0)20 3077 6278

FTI Consulting - PR to Ashmore Group plcAndrew Walton +44 (0)20 3727 1514Paul Marriott +44 (0)20 3727 1341

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTSSAFMUFLSEIW
Date   Source Headline
8th Nov 20224:20 pmRNSHolding(s) in Company
28th Oct 202210:13 amRNSHolding(s) in Company
14th Oct 20222:11 pmRNSResult of AGM
14th Oct 20227:00 amRNSTrading Statement
5th Oct 20226:03 pmRNSHolding(s) in Company
23rd Sep 20224:56 pmRNSDirector/PDMR Shareholding
15th Sep 202210:36 amRNSDirector/PDMR Shareholding
14th Sep 20226:00 pmRNSHolding(s) in Company
9th Sep 20225:19 pmRNSNotice of AGM
2nd Sep 20227:00 amRNSFinal Results
22nd Jul 202211:33 amRNSDirectorate Change
14th Jul 20227:00 amRNSTrading Statement
25th Apr 20227:00 amRNSHolding(s) in Company
14th Apr 20227:00 amRNSTrading Statement
1st Apr 20223:02 pmRNSDirector/PDMR Shareholding
21st Mar 20224:30 pmRNSDirectorate Change
17th Mar 202211:35 amRNSDirector/PDMR Shareholding
17th Jan 20227:00 amRNSTrading Statement
13th Dec 202111:34 amRNSDirector/PDMR Shareholding
15th Oct 20213:42 pmRNSResult of AGM
14th Oct 20217:00 amRNSTrading Statement
23rd Sep 202112:27 pmRNSDirector/PDMR Shareholding
23rd Sep 202112:24 pmRNSDirector/PDMR Shareholding
17th Sep 20219:52 amRNSDirector/PDMR Shareholding
17th Sep 20219:48 amRNSDirector/PDMR Shareholding
10th Sep 20214:00 pmRNSNotice of AGM
3rd Sep 20217:00 amRNSFinal Results
14th Jul 20217:00 amRNSTrading Statement
30th Apr 20212:51 pmRNSDirector/PDMR Shareholding
23rd Apr 20213:12 pmRNSDirectorate Change
16th Apr 20217:00 amRNSTrading Statement
13th Apr 20213:45 pmRNSAGM voting result update statement
6th Apr 20212:54 pmRNSDirector/PDMR Shareholding
6th Apr 20212:37 pmRNSDirector/PDMR Shareholding
18th Mar 20216:02 pmRNSDirector/PDMR Shareholding
16th Feb 20214:35 pmRNSHolding(s) in Company
16th Feb 20214:29 pmRNSDirector/PDMR Shareholding
10th Feb 20217:00 amRNSHalf-year Report
15th Jan 20217:00 amRNSTrading Statement
11th Dec 20205:40 pmRNSDirector/PDMR Shareholding
11th Dec 20205:37 pmRNSDirector/PDMR Shareholding
19th Oct 20206:20 pmRNSHolding(s) in Company
19th Oct 20205:47 pmRNSDirector/PDMR Shareholding
16th Oct 20204:14 pmRNSResult of AGM
14th Oct 20207:00 amRNSTrading Statement
7th Oct 20209:42 amRNSHolding(s) in Company
25th Sep 20202:20 pmRNSAGM arrangements
22nd Sep 20206:04 pmRNSDirector/PDMR Shareholding
22nd Sep 20206:03 pmRNSDirector/PDMR Shareholding
22nd Sep 20208:26 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.